Dominant mutations in BCL2-associated athanogene 3 (BAG3) cause a rapidly progressive childhood- or adolescence-onset myofibrillar myopathy with limb and axial weakness, peripheral neuropathy, respiratory failure and a severe dilated cardiomyopathy (Selcen et al., 2009). This evidence concerns the gene BAG3 and myofibrillar myopathy.